Close Menu

NEW YORK (GenomeWeb) – Fluidigm and Visiopharm have signed a comarketing agreement to automate image analysis for imaging mass cytometry, the companies said today.

Under the agreement, Fluidigm and Visiopharm will copromote Visiopharm's Phenomap image-analysis software alongside Fluidigm's Hyperion imaging system, MCD Viewer software, and related Maxpar antibodies and kits.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.

The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.

Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.